Salesforce Target price 2026 - Analyst rating & recommendation
Salesforce Classifications & Recommendation
Salesforce Price Target
| Target Price | $281.01 |
| Price | $236.69 |
| Potential | 18.72% |
| Number of Estimates | 53 |
| 53 Analysts have issued a price target Salesforce 2027 . The average Salesforce target price is $281.01. This is 18.72% higher than the current stock price. The highest price target is $498.75 110.72% , the lowest is $161.60 31.73% . | |
| A rating was issued by 59 analysts: 44 Analysts recommend Salesforce to buy, 13 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Salesforce stock has an average upside potential 2027 of 18.72% . Most analysts recommend the Salesforce stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2034
55 Analysts have issued a sales forecast Salesforce 2027 . The average Salesforce sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an Salesforce EBITDA forecast 2027. The average Salesforce EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
55 Salesforce Analysts have issued a net profit forecast 2027. The average Salesforce net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2034
55 Analysts have issued a Salesforce forecast for earnings per share. The average Salesforce EPS is
This results in the following potential growth metrics and future valuations:
Current Salesforce Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 18 2026 |
| Stephens & Co. |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Sep 18 2026 |
| Citizens |
Market Outperform
➜
Market Outperform
|
Unchanged | Sep 18 2026 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Sep 17 2026 |
| Canaccord Genuity |
Buy
➜
Buy
|
Unchanged | Sep 17 2026 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Sep 17 2026 |
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Sep 17 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Sep 18 2026 |
|
Unchanged
Stephens & Co.:
Equal-Weight
➜
Equal-Weight
|
Sep 18 2026 |
|
Unchanged
Citizens:
Market Outperform
➜
Market Outperform
|
Sep 18 2026 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Sep 17 2026 |
|
Unchanged
Canaccord Genuity:
Buy
➜
Buy
|
Sep 17 2026 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Sep 17 2026 |
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Sep 17 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
